The use of 3D imaging for the detection of ALK fusion in CTCs was tested in a small cohort of lung cancer patients: comparing subjects with ALK-positive and ALK-negative NSCLC, the assay was able to capture a good probes signal separation, indicative of ALK translocations, by nuclear volume imaging. This evidence concerns the gene ALK and lung carcinoma.